Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.8 INR | +0.47% | -0.40% | +7.92% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.92% | 2.36B | |
+32.36% | 694B | |
+29.71% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.42% | 239B | |
-3.48% | 209B | |
+10.05% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Jefferies Adjusts Piramal Pharma’s Price Target to INR115 From INR150, Keeps at Buy